# Session handoff — 2026-07-03 (close)

Research / PAPER only. Nothing live traded. Frozen S0/regime config untouched throughout.

## Orientation
A broad session across four fronts, plus overnight triage. Net: the CANSLIM ratings replica advanced to Phase 2 and the IBD composites were locked display-only; the CANSLIM options overlay was refuted as a pivot-entry standalone; BOTH structural regime leads for the whipsaw/re-entry bleed were closed (intraday-gamma shelved, re-entry ladder refuted), leaving that bleed near-irreducible; the intraday 0DTE condor's last surviving lead (morning-rvol) was refuted, parking that line four ways over; the dashboard gained a GEX flip chart + an S5 convexity panel; and the free IBKR survivor price pull was built, hardened, and set running unattended. One important NEW empirical finding: the survivor count is running LOW, which promotes the paid delisted price source to the critical path for CANSLIM Phase 3.

## Overnight triage (logged + verified this session)
- **EOD email crash + Tiingo false-`partial`** — both bit 2026-07-02 night, both already fixed in `cac0e9e`, both now INDEPENDENTLY VERIFIED this session (`cdc49f2`): `render_html` renders clean incl. a forced synthetic `partial` section (the exact 21:00 crash path) via a no-send dry-run, and the Tiingo manifest now resolves through `config.MANIFEST_FILE` to the real off-Drive path. The mailer SEND path was deliberately NOT exercised (to avoid a duplicate email) — it is first-proven only at tonight's live 21:00.
- **CANSLIM overlay double-email 2026-07-02** — 19:00 placeholder (false-complete resume on a stale test heartbeat, fixed `0acd9ee`) then correct at 21:47. **Trust the 21:47 email** (option base $805,656 vs stock $950,167). The equity-options PULL itself SUCCEEDED (2407/2407 name-months, 17.3M rows, 0 failed); `pull_equity_options_poison.json` is benign current-day skips.

## What shipped / was decided (all honest, nothing curve-fit, frozen config untouched)

### CANSLIM
- **Phase 2 ratings replica BUILT** (`108b065`): deterministic C/A/N/S/L + RS-rank from point-in-time EDGAR fundamentals + prices. I (institutional) and S-float are marked **unavailable, not faked**. No-lookahead tested; 8 new tests.
- **IBD composite grades LOCKED display-only** (`3816320`): EPS/SMR/Composite confirmed already display-only, now pinned with a **guard test** that composite weights can't change a selection. Phase 3 selection gates ONLY on raw spec-pinned components: C ≥25% YoY, A ≥25%/yr×3 + ROE ≥17%, N near-52wk-high, L RS ≥80.
- **Options overlay (pivot-entry, real quotes) REFUTED as a standalone** — base cell option $805,656 vs stock $950,167 (the 21:47 verdict). The FRONTIER is **anticipatory pre-IV-spike (early-base) entry**, still UNTESTED. Do NOT confuse it with the refuted pivot-entry overlay.

### Regime research — both structural leads CLOSED
- **(a) intraday-gamma early-exit — Step 0 SHELVED as a config change.** Read-only, frozen config: counted only **8 S0 regime transitions** (4 exits + 4 re-entries, ~2-3 whipsaw-shaped, mostly the 2022 bear) inside the 2022-2026 intraday dealer-gamma window — far too few to validate without curve-fitting. **ALERT-ONLY is the ceiling**; accumulate forward OOS evidence, never wire in a rule on this data.
- **(b) re-entry ladder — BUILT + REFUTED** (`18f8173`, banked negative). Pre-registered 3-rung TIME-BASED ladder (`backtester/src/reentry_ladder.py`, overlay default-OFF, OFF-parity byte-identical to production): costs CAGR (Balanced 7.81%→7.50%) with **ZERO drawdown benefit** (maxDD unchanged −9.66%; exits untouched), makes the exact 2011/2015-16 grinds it targeted WORSE, and **loses to a beta-matched flat-haircut placebo on 5/6 episodes** — so the re-entry TIMING adds nothing. OOS-robust failure. 8 new tests. Evidence: `backtester/output/reentry_ladder_20260703.md`.
- **Conclusion:** the ladder was the last-standing structural candidate. With the knobs already a robust plateau and intraday-gamma shelved, the re-entry/whipsaw bleed is **near-IRREDUCIBLE** — S0's frozen config sits at its honest frontier. **Stop tuning re-entry.** Only untested residual = the breadth-thrust re-entry signal (low prior, needs breadth data 2007-2026 we don't have).

### Intraday 0DTE condor — morning-rvol REFUTED
- The last surviving lead (morning-rvol→PM-range, Spearman +0.59) is refuted (`d9b021b`): all 3 pre-registered arms (gate 87.0% / downsize 86.9% / widen 97.2%) die at the matched placebo (≥98% Bonferroni multiple-comparisons bar). Root cause: morning vol predicts afternoon RANGE, but the sold credit AND the strike widths scale with the same vol, so a bigger range is NOT a bigger loss. Intraday 0DTE iron-condor line now **refuted 4 ways → PARKED.** 12 new tests.

### Dashboard
- **L1 GEX zero-line/flip chart + V2 S5 convexity panel shipped** (`40d7e14`; read-only preserved). **L2 per-strike gamma grid BLOCKED** on a datacollector per-strike-GEX build.

### Data sourcing — clarify the two worlds
- *World 1* = ThetaData options warehouse (COMPLETE; feeds S5 / S2S3 / gamma). *World 2* = CANSLIM full-universe stock PRICES — **the only real gap** (Tiingo free tier landed ~49 of 16,725). Fundamentals already OWNED free via SEC EDGAR.
- **Free IBKR survivor price pull BUILT + smoke-clean + LIVE + HARDENED** (`b225714`): Windows task `CanslimIbkrPriceGapfill`, run-whether-logged-on, cross-process singleton-guarded, clientId 43, Tiingo-schema match, resumable/checkpointed watchdog. Delisted names logged (`_state/ibkr_unresolved.json`), never fabricated, deferred to a future paid pull.
- **NEW FINDING — survivor resolution trending LOW:** ~2,070 resolved / ~9,930 deferred at ~72% through the universe → likely ~**2,900 survivors / ~13,800 delisted**, well below the audit's ~6k survivor estimate. This promotes the **paid delisted price source** from "nice-to-have" to the central Phase-3 gate.

## Commits (verified on disk)
- `cdc49f2` — status: log + verify the overnight EOD-crash + Tiingo false-partial fixes (no-send dry-run + manifest-path check).
- `108b065` — canslim: Phase 2 deterministic CAN SLIM ratings replica (C/A/N/S/L/RS from point-in-time EDGAR+prices; I/S-float unavailable not faked; no-lookahead tested; 8 tests).
- `40d7e14` — dashboard: L1 GEX zero-line/flip chart + V2 S5 convexity panel (read-only preserved; L2 grid blocked on datacollector build).
- `d9b021b` — backtester: S2/S3 morning-rvol signal REFUTED (all 3 pre-registered arms die at the matched placebo; intraday 0DTE condor refuted 4 ways; 12 tests).
- `3816320` — canslim: lock IBD composite grades display-only (Phase 3 gates on raw spec-pinned components only) + guard test.
- `18f8173` — backtester: re-entry ladder REFUTED (pre-registered 3-rung time-based ladder costs CAGR, no DD benefit, loses to a beta-matched placebo 5/6 episodes; overlay default-OFF, OFF-parity byte-identical; 8 tests).
- `b225714` — canslim: IBKR historical daily-price gap-fill puller (free survivor coverage; resumable/checkpointed, clientId 43, Tiingo-schema match, singleton guard + run-whether-logged-on launcher; delisted deferred to a paid pull).

## Ops notes
- Tests (worker-reported green): **199 backtester** + causality (no-lookahead) guard, **64 canslim**.
- Frozen S0/regime config UNTOUCHED. All PAPER; nothing armed, nothing transmitted.

## OPEN ITEMS / NEXT ACTIONS
- **IBKR survivor pull running unattended** (hardened/self-resuming). Next session: run `python canslim/ibkr_price_gapfill.py status` and report the FINAL resolved/deferred split — that number drives the paid-data call.
- **PAID delisted price source** (~$100/mo EODHD, one month, retention-OK; we need PRICES only since EDGAR fundamentals are owned) — OPEN, **Andrew's call**, now MORE central given the low survivor count (~2,900 est).
- **CANSLIM Phase 3 (selection backtest)** — gated on the price data landing (survivors + delisted).
- **Tonight 21:00 EOD email = first live SEND under the fixes** (render + Tiingo verified this session; the mailer SEND itself is the only unproven piece). If no email arrives, check Desktop for `TRADINGDESK_EMAIL_DOWN.txt`.
- **When the pull completes** (`resolved & still to pull : 0`): remove the task — `Unregister-ScheduledTask -TaskName CanslimIbkrPriceGapfill -Confirm:$false`.
- **CANSLIM options-overlay frontier** (anticipatory pre-IV-spike / early-base entry) — untested lead; do NOT confuse with the refuted pivot-entry overlay.
- **Dashboard L2 per-strike gamma grid** — blocked on a datacollector per-strike-GEX build.
- **Breadth-thrust re-entry signal** — the only untested regime lead; parked (low-prior, high curve-fit risk, needs breadth data 2007-2026).
- **PRE-EXISTING UNCOMMITTED work left untouched** (flag for Andrew's decision — DO NOT commit): `canslim/research/options_overlay_real.md` (modified), `canslim/research/overlay_pipeline_summary.md`, `backtester/s6_strike_experiment.py`, `backtester/s6_zones.py`, `backtester/tests/test_s6_strike_experiment.py`, `backtester/tests/test_s6_zones.py`, `Brandon W/`.

## Pick up here (next session)
1. **Check the IBKR survivor pull** — `python canslim/ibkr_price_gapfill.py status`; report the final resolved/deferred split. If done, unregister the task.
2. **Make the paid delisted-price call** (Andrew) — now the gate to CANSLIM Phase 3 given the low survivor count.
3. Confirm tonight's 21:00 EOD email actually SENT under the fixes.
